Browse through the Gavi publications library that includes fact sheets, annual progress reports, PowerPoint presentations, technical updates, research and partner materials
Browse through the Gavi publications library that includes fact sheets, annual progress reports, PowerPoint presentations, technical updates, research and partner materials
This document is designed to guide country applications for cold chain equipment (CCE) support, providing a structured approach to CCE purchasing decisions. It helps identify which devices comply with the requirements of Gavi's cold chain equipment platform, allowing countries to choose solutions that best meet the needs of their health facilities.
Exploring current approaches to leaving no child behind with immunisation by harnessing geospatial technologies and GIS to improve immunisation coverage and equity in low- and middle-income countries.
Building upon two decades of experience in accelerating the availability of billions of doses of vaccines, Gavi is launching an investment opportunity: the Gavi Advance Market Commitment for COVID-19 Vaccines (Gavi Covax AMC).
New publication illustrates how the different members of the Vaccine Alliance work together and bring their unique skills and competencies to our public-private partnership.
The Investment Opportunity for the 2021-2025 period highlights the Alliance’s ambition to build on its success by providing the most comprehensive package of protection yet.
The Alliance has played a key role in increasing immunisation coverage across the continent by introducing nine vaccines providing protection against 13 vaccine-preventable diseases.
In this edition of our Annual Progress Report, we look back at the third year of the 2016-2020 strategic period and provide a global context for the work of the Vaccine Alliance.
The Investment Opportunity for the 2021-2025 period highlights the Alliance’s ambition to build on its success by providing the most comprehensive package of protection yet.
The Investment Opportunity for the 2021-2025 period highlights the Alliance’s ambition to build on its success by providing the most comprehensive package of protection yet.
Strong supply chains are a critical part of Gavi’s goal to help countries increase the effectiveness and effi ciency of immunisation delivery as an integrated part of health systems.
Immunisation serves as a strong foundation on which to build universal health coverage (UHC). Download this factsheet to learn more about Gavi’s role in strengthening healthcare systems to advance UHC.
Published midway through the 2016–2020 reporting period, this 20-page report describes Gavi’s progress in delivering on the Investment Opportunity commitments made at the 2015 Berlin pledging conference as well as how the Alliance is adjusting to its remaining challenges and setting a vision for the future.
High-level, two-page overview of Gavi’s progress in delivering on its Investment Opportunity commitments, adjusting to its remaining challenges and setting out a vision for the future.
Launched at Davos in 2016, Innovation for Uptake, Scale and Equity in Immunisation (INFUSE) seeks tried and tested innovations that have potential to improve vaccine delivery. It then “infuses” them with capital and expertise to help take them to scale.
The 2011-2015 period was centered on delivering on the promise of saving children’s lives and protecting people’s health by increasing access to immunisation in the poorest countries.
The innovative Strategic Training Executive Programme (STEP) is helping immunisation supply chain managers across the East African Community to hone their skills and provide more effective supply chain leadership.
The upcoming 2016–2020 strategy period presents a tremendous opportunity to accelerate impact, reach more children with the power of vaccines, and ensure the gains made to date are consolidated and sustained, enabling a healthy future for the next generation.
The upcoming 2016–2020 strategy period presents a tremendous opportunity to accelerate impact, reach more children with the power of vaccines, and ensure the gains made to date are consolidated and sustained, enabling a healthy future for the next generation.
Thanks to the power of vaccines, more and more children in poor countries are growing up healthier, enabling them to spend more time at school and giving them the chance of a healthy, productive life. The GAVI Alliance exists to redress global inequities in access to new and underused vaccines.
The annual progress report gives a comprehensive overview of the activities and performance of the GAVI Alliance, illustrating the work and achievements of this public-private partnership.
GAVI’s mission is to save children’s lives and protect people’s health by increasing access to immunisation in poor countries. To that end, GAVI has become a leading force in the use of innovative finance to fund development initiatives that help GAVI. Learn more in this brochure.
The annual progress report gives a comprehensive overview of the activities and performance of the GAVI Alliance, illustrating the work and achievements of this public-private partnership.
Marking the end of GAVI's first decade, the 2010 Progress Report shows how unprecedented demand, accelerated access to vaccines and strong country ownership have helped save over five million future deaths.
GAVI's 2009 Progress Report paints a picture of developing country commitment and ownership of GAVI programmes. By the end of the year, over 250 million additional children had been vaccinated through GAVI support.
The purpose of these case studies is to document experiences and lessons learned under the GAVI CSO grant, including the application and selection process, implementation to date, and monitoring and reporting.
By the end of 2008, 3.4 million future deaths have been averted through GAVI support for vaccines. In 2008, GAVI undergoes governance and administrative changes, becoming a Swiss international organisation.
2007 was a landmark year for GAVI: it was the initial year of GAVI's first strategic plan; the new health system strengthening programme starts; over 80% of countries eligible for support receive funding for NVS, INS and ISS.
2007 was a landmark year for GAVI: it was the initial year of GAVI's first strategic plan; the new health system strengthening programme starts; over 80% of countries eligible for support receive funding for NVS, INS and ISS.
In the first five years of GAVI, 15 million more children were reached with basic vaccines, 99 million were reached with new vaccines and 1.2 billion auto-disable syringes were delivered.
After five years in operation, 71 countries out of 75 GAVI-eligible countries have received GAVI support, with one third of resources directed toward strengthening health systems in poorest countries.